Biotest, ADMA sign manufacturing deal
News | 14 January 2013
Biotest Pharmaceuticals (BPC), a wholly owned US subsidiary of Biotest, and ADMA Biologics have signed a strategic long-term manufacturing, supply and licensing deal. According to the deal, BPC will provide manufacturing services and license ...
Click on the link to read the full article at Pharmaceutical Business Review
(This link will open in a new window)
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
